NCT04917744View on ClinicalTrials.gov

Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors

CompletedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

April 17, 2023

Study Completion Date

February 17, 2024

Conditions
Ovarian Carcinoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

OTHER

Laboratory Biomarker Analysis

Ancillary studies

OTHER

Medical Chart Review

Review of medical charts

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04917744 - Metabolite Levels in Ovarian Cancer Patients Receiving Maintenance PARP Inhibitors | Biotech Hunter | Biotech Hunter